Bioforce Nanosciences Holdings Income Statement (2019-2025) | BFNH

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Selling, General & Administrative (Quarter)
0.04M0.02M0.01M0.01M0.03M0.01M0.02M0.01M0.02M0.01M0.01M0.01M0.03M0.01M0.02M0.02M0.03M0.02M0.01M
Other Operating Expenses (Quarter)
0.11M0.11M0.11M0.11M0.01M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M
Operating Expenses (Quarter)
0.15M0.12M0.11M0.12M0.03M0.12M0.12M0.11M0.13M0.11M0.11M0.11M0.13M0.11M0.12M0.12M0.13M0.12M0.12M
Operating Income (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M
EBIT (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M
Non-operating items
Other Non Operating Income (Quarter)
-0.80M
Net income details
EBT (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M
Profit After Tax (Quarter)
-0.15M-0.12M-0.11M-0.12M-0.13M-0.12M-0.12M-0.11M-0.13M-0.11M-0.11M-0.11M-0.13M-0.11M-0.12M-0.12M-0.93M-0.12M-0.12M
Income from Continuing Operations (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M
Consolidated Net Income (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M
Income towards Parent Company (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M
Net Income towards Common Stockholders (Quarter)
-0.13M-0.11M-0.12M-0.93M-0.12M-0.12M
Additional items
EPS (Basic) (Quarter)
29.27M-0.0129.27M-0.03-0.010.000.000.00-0.01-0.030.000.00
EPS (Weighted Average and Diluted) (Quarter)
-0.03-0.010.000.000.00-0.01-0.030.000.00
Shares Outstanding (Weighted Average) (Quarter)
29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M32.25M33.52M33.52M33.21M
Shares Outstanding (Diluted Average) (Quarter)
29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M29.27M32.25M33.52M33.10M33.21M
EBITDA (Quarter)
-0.11M-0.12M-0.13M-0.12M-0.12M